![“COVID-19 crisis has brought together the scientific community like never before”](https://magarticles.magzter.com/articles/11639/463355/5edf38cf70ac7/COVID-19-crisis-has-brought-together-the-scientific-community-like-never-before.jpg)
What are the major plans in store for Cytiva? Any new segments to be explored?
Cytiva offers the same high-quality services as we did when we were part of GE Healthcare Life Sciences. It shouldn’t be overlooked that we are already a life sciences global leader and we expect our significant growth of recent years to continue. We have been at the forefront of innovation and development of areas such as protein purification, single-use technology and cell and gene therapies. Cytiva will benefit from being a newly-created organization that is already a global life sciences leader. We have market-leading brands such as ÄKTA, Amersham, HyClone and Whatman, among others. We also have more than 100,000 systems in use globally. We will continue innovating from within and working with our customers to develop next-generation solutions. One area where we want to and must do better is sustainability. This is a challenge and opportunity for any organization operating today and one that Cytiva takes very seriously. We don’t want to be just compliant in sustainability terms, we want to lead the industry. We will be focusing on areas such as GHG emission, use of plastics, packaging, water management and societal impact among other areas.
This story is from the June 2020 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the June 2020 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
![Ushering Fourth Industrial Revolution in Telangana](https://reseuro.magzter.com/100x125/articles/11639/1649091/f7ZgH160d1711997226260/USHERING-FOURTH-INDUSTRIAL-REVOLUTION-IN-TELANGANA.jpg)
Ushering Fourth Industrial Revolution in Telangana
Taking advantage of the 21st edition of BioAsia 2024 at the Hyderabad International Convention Centre (HICC) in Madhapur, the Government of Telangana, a southern state in India, leveraged the confluence of the global platform to spearhead initiatives aimed at propelling the state into the forefront of the Fourth Industrial Revolution (C4IR).
![How Indian Biotech Investments are on a Doubling Spree](https://reseuro.magzter.com/100x125/articles/11639/1649091/VEVbGpT841711996980790/HOW-INDIAN-BIOTECH-INVESTMENTS-ARE-ON-A-DOUBLING-SPREE.jpg)
How Indian Biotech Investments are on a Doubling Spree
A latest report by Ankur Capital provides a closer look at the investments made in biotechnology in the last decade in the country.
!["AI will be integrally involved in not only the diagnosis of cancer but also in determining the prognosis and best therapeutic option”](https://reseuro.magzter.com/100x125/articles/11639/1649091/nIHogUVC_1711996808759/AI-WILL-BE-INTEGRALLY-INVOLVED-IN-NOT-ONLY-THE-DIAGNOSIS-OF-CANCER-BUT-ALSO-IN-DETERMINING-THE-PROGNOSIS-AND-BEST-THERAPEUTIC-OPTION.jpg)
"AI will be integrally involved in not only the diagnosis of cancer but also in determining the prognosis and best therapeutic option”
South Korea-based Deep Bio, a pioneering artificial intelligence (AI) healthcare firm focused on cancer pathology, is making waves in the industry.
!["Because of its specificity and selectivity, ADCS have the potential to reduce adverse side effects and improve patient survival"](https://reseuro.magzter.com/100x125/articles/11639/1649091/Ahwvf_IuS1711996599008/BECAUSE-OF-ITS-SPECIFICITY-AND-SELECTIVITY-ADCS-HAVE-THE-POTENTIAL-TO-REDUCE-ADVERSE-SIDE-EFFECTS-AND-IMPROVE-PATIENT-SURVIVAL.jpg)
"Because of its specificity and selectivity, ADCS have the potential to reduce adverse side effects and improve patient survival"
Japan-headquartered Daiichi Sankyo, the global healthcare company, launched its subsidiary Daiichi Sankyo Singapore Pte. Ltd. to bridge unmet needs in oncology.
![Can Test, Treat, Track Beat Malaria?](https://reseuro.magzter.com/100x125/articles/11639/1649091/9ANK3QTjN1711996370081/CAN-TEST-TREAT-TRACK-BEAT-MALARIA.jpg)
Can Test, Treat, Track Beat Malaria?
Malaria has long been a major public health concern in the Asia Pacific region, particularly in South East Asia (SEA) affecting millions of people.
![Engineering CAR T cell sharpshooters](https://reseuro.magzter.com/100x125/articles/11639/1649091/6zEHFQOrT1711996123002/ENGINEERING-CAR-T-CELL-SHARPSHOOTERS.jpg)
Engineering CAR T cell sharpshooters
Approved CAR T-cell therapies have shown remarkable results in patients with certain types of blood cancers.
![Addressing Challenges in Cell Therapy Manufacturing](https://reseuro.magzter.com/100x125/articles/11639/1649091/TeKcz4NQ91711995999763/ADDRESSING-CHALLENGES-IN-CELL-THERAPY-MANUFACTURING.jpg)
Addressing Challenges in Cell Therapy Manufacturing
Even with significant advancements, there are still anumber of issues with cell therapy manufacturing that need to be resolved as production grows.
!["We anticipate India will adopt decentralised models for managing CGTs, ensuring closer proximity between patients and treatment facilities"](https://reseuro.magzter.com/100x125/articles/11639/1649091/u_p-H2gvH1711995799331/WE-ANTICIPATE-INDIA-WILL-ADOPT-DECENTRALISED-MODELS-FOR-MANAGING-CGTS-ENSURING-CLOSER-PROXIMITY-BETWEEN-PATIENTS-AND-TREATMENT-FACILITIES.jpg)
"We anticipate India will adopt decentralised models for managing CGTs, ensuring closer proximity between patients and treatment facilities"
Cell and gene therapy (CGT) expert from Germany, Miltenyi Biotec has recently announced its entry into the Indian market to provide researchers, scientists and clinicians easier access to expertise, research, and manufacturing solutions.
![Addressing Accessibility and Affordability of CELL & GENE THERAPIES](https://reseuro.magzter.com/100x125/articles/11639/1649091/jRI-14zn71711995205295/ADDRESSING-ACCESSIBILITY-AND-AFFORDABILITY-OF-CELL-GENE-THERAPIES.jpg)
Addressing Accessibility and Affordability of CELL & GENE THERAPIES
Cell and gene therapies (CGT) are one of the hottest sectors in the pharmaceutical industry.
![Korea designs sweat resistant wearable robot sensor](https://reseuro.magzter.com/100x125/articles/11639/1619224/2XRZ1zFeG1709558860289/KOREA-DESIGNS-SWEAT-RESISTANT-WEARABLE-ROBOT-SENSOR.jpg)
Korea designs sweat resistant wearable robot sensor
New electromyography (EMG) sensor technology that allows the long-term stable control of wearable robots and is not affected by the wearer's sweat and dead skin has gained attention recently.